TJX Companies (TJX) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
25 Feb, 2026Executive summary
Q4 and full-year results exceeded expectations, with comp sales up 5% across all divisions and strong profitability growth.
Annual net sales surpassed $60 billion for the first time, with double-digit EPS growth and all divisions posting at least 4% comp sales growth.
Q4 adjusted diluted EPS was $1.43, up 16% YoY; Q4 diluted EPS rose 28% YoY to $1.58.
Returned $4.3 billion to shareholders in FY26 via buybacks and dividends.
Q1 of fiscal 2026 started strong, with ongoing investments in store remodels and new formats.
Financial highlights
Q4 net sales reached $17.7 billion, up 9% YoY; full-year net sales were $60.4 billion, up 7% YoY.
Q4 adjusted pre-tax profit margin was 12.2% (+60 bps YoY); Q4 gross profit margin was 30.9%, up 0.4 pts; adjusted gross margin 31.1%, up 0.6 pts.
Q4 net income was $1.8 billion; full-year net income was $5.5 billion.
Operating cash flow for the year was $6.9 billion; year-end cash $6.2 billion.
Inventory at year-end was $7.3 billion, up 10% per store on a reported basis.
Outlook and guidance
FY27 guidance: comparable sales up 2–3%, sales expected at $62.7–$63.3 billion (+4%–5%), pretax profit margin 11.7%–11.8%, gross margin 31.1%–31.2%, diluted EPS $4.93–$5.02.
Q1 FY27 guidance: sales expected at $13.8–$13.9 billion (+5%–6%), comparable sales up 2–3%, pretax profit margin 10.3%–10.4%, EPS $0.97–$0.99 (+5%–8% YoY).
Capital expenditures planned at $2.2–$2.3 billion, with 146 net new stores and 540 remodels.
Latest events from TJX Companies
- Q2 sales and profit margins exceeded expectations; FY25 guidance and global investments increased.TJX
Q2 202523 Jan 2026 - Q3 net sales up 6% to $14.1B, EPS $1.14, with raised outlook and global expansion.TJX
Q3 202513 Jan 2026 - Sales, profitability, and EPS surpassed expectations, with strong growth and expansion plans.TJX
Q4 20257 Jan 2026 - Q3 FY26 sales up 7%, EPS up 12% to $1.28, and $1.1B returned to shareholders.TJX
Q3 20262 Dec 2025 - FY25 saw robust growth, strong returns, and enhanced ESG initiatives, with all Board proposals recommended for approval.TJX
Proxy Filing1 Dec 2025 - Key votes include board elections, auditor ratification, and executive pay approval.TJX
Proxy Filing1 Dec 2025 - Q2 net sales up 7%, comp sales up 4%, EPS up 15%, and guidance raised.TJX
Q2 202623 Nov 2025 - Q1 FY26 sales up 5% with strong comp growth and EPS, guidance maintained despite margin pressures.TJX
Q1 202618 Nov 2025